Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation

被引：0
|
作者：
Liuzzo, Giovanna [1 ,2 ]
Patrono, Carlo [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Catholic Univ, Sch Med, Cardiovasc & Pulm Sci, Largo F Vito 1, I-00168 Rome, Italy
[3] Catholic Univ, Pharmacol, Sch Med, Largo F Vito 1, I-00168 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 06期
关键词：
EFFICACY; REGISTRY; SAFETY;
D O I：
10.1093/eurheartj/ehac721
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [1] The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
    Karthikeyan, Ganesan
    Connolly, Stuart J.
    Ntsekhe, Mpiko
    Benz, Alexander
    Rangarajan, Sumathy
    Lewis, Gayle
    Yun, Yan
    Sharma, Sanjib Kumar
    Maldady, Fathi
    Elghamrawy, Alaa Eldin
    Kazmi, Khawar
    Cabral, Tantchou T. J.
    Dayi, Hu
    Ma Changsheng
    Gitura, Bernard M.
    Avezum, Alvaro
    Zuhlke, Liesl
    Lwabi, Peter
    Haileamlak, Abraham
    Ogah, Okechukwu
    Chillo, Pilly
    Paniagua, Maria
    ElSayed, Ahmed
    Dans, Antonio
    Gondwe-Chunda, Lillian
    Molefe-Baikai, Onkabetse Julia
    Gonzalez-Hermosillo, Jesus A.
    Hakim, James
    Damasceno, Albertino
    Kamanzi, Emmanuel R.
    Musuku, John
    Davletov, Kairat
    Connolly, Katherine
    Mayosi, Bongani M.
    Yusuf, Salim
    AMERICAN HEART JOURNAL, 2020, 225 : 69 - 77
  • [2] Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease
    Lip, Gregory Y. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1036 - 1038
  • [3] Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
    Cappato, Riccardo
    Ezekowitz, Michael D.
    Klein, Allan L.
    Camm, A. John
    Ma, Chang-Sheng
    Le Heuzey, Jean-Yves
    Talajic, Mario
    Scanavacca, Mauricio
    Vardas, Panos E.
    Kirchhof, Paulus
    Hemmrich, Melanie
    Lanius, Vivian
    LingMeng, Isabelle
    Wildgoose, Peter
    van Eickels, Martin
    Hohnloser, Stefan H.
    EUROPEAN HEART JOURNAL, 2014, 35 (47) : 3346 - 3355
  • [4] Comparison of factor X inhibitors versus vitamin K antagonists in atrial fibrillation patients on dialysis
    Chen, Xi
    Zhu, Wengen
    Lin, Meiming
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 154 - 156
  • [5] Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease
    Posch, Florian
    Ay, Cihan
    Stoeger, Herbert
    Kreutz, Reinhold
    Beyer-Westendorf, Jan
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 207 - 216
  • [6] Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
    Li, Wenhao
    Zhou, Yanxia
    Chen, Siqi
    Zeng, Dewang
    Zhang, Haidong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
    Connolly, S. J.
    Karthikeyan, G.
    Ntsekhe, M.
    Haileamlak, A.
    El Sayed, A.
    El Ghamrawy, A.
    Damasceno, A.
    Avezum, A.
    Dans, A. M. L.
    Gitura, B.
    Hu, D.
    Kamanzi, E. R.
    Maklady, F.
    Fana, G.
    Gonzalez-Hermosillo, J. A.
    Musuku, J.
    Kazmi, K.
    Zuhlke, L.
    Gondwe, L.
    Ma, C.
    Paniagua, M.
    Ogah, O. S.
    Molefe-Baikai, O. J.
    Lwabi, P.
    Chillo, P.
    Sharma, S. K.
    Cabral, T. T. J.
    Tarhuni, W. M.
    Benz, A.
    van Eikels, M.
    Krol, A.
    Pattath, D.
    Balasubramanian, K.
    Rangarajan, S.
    Ramasundarahettige, C.
    Mayosi, B.
    Yusuf, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 978 - 988
  • [8] Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists
    Gieling, Emilie
    de Vries, Frank
    Williams, Rachael
    van Onzenoort, Hein A. W.
    de Boer, Anthonius
    ten Cate, Vincent
    Kramers, Cornelis
    Burden, Andrea
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (06) : 1536 - 1544
  • [9] Oral anticoagulation for atrial fibrillation in rheumatic heart disease
    Dougherty, Scott
    Nascimento, Bruno
    Okello, Emmy
    EUROPEAN HEART JOURNAL, 2023, 44 (27) : 2440 - 2442
  • [10] Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease
    Benz, Alexander P.
    Healey, Jeff S.
    Chin, Ashley
    Commerford, Patrick
    Marsden, Tamara
    Karthikeyan, Ganesan
    McIntyre, William F.
    Wong, Jorge A.
    Damasceno, Albertino
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Wallentin, Lars
    Ezekowitz, Michael D.
    Eikelboom, John W.
    Yusuf, Salim
    Connolly, Stuart J.
    CARDIOVASCULAR RESEARCH, 2022, 118 (01) : 295 - 304
12345